Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Publication|Articles|October 23, 2023
- October 2023
- Volume 89
- Issue 10
Pharmacists Pet Peeves: October 2023
Advertisement
You Snooze, You Lose
When the prescription was waiting for pickup for 14 days so we return it to stock, but the patient gets mad that they have to wait 20 minutes for us to refill it again.
Articles in this issue
almost 3 years ago
Interactive Case Studies: October 2023almost 3 years ago
Condition State Management: Stroke Watchalmost 3 years ago
Celebrate Pharmacists Who Are Trailblazers in MTMalmost 3 years ago
Weight Loss: OTC Case Studiesalmost 3 years ago
Counsel Patients, Parents on the HPV Vaccinealmost 3 years ago
Generic Product News: October 2023almost 3 years ago
RX Product News: October 2023almost 3 years ago
The Medical Marijuana and Cannabidiol Research Expansion ActAdvertisement
Related to this article
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1c reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
In a FINE-HEART analysis, cancer history raised the risk of death and hospitalization but did not blunt finerenone's cardiovascular and kidney benefits.
Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
Marie-Claire Seeley, PhD, MNurs, RN, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
2
Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study
5